Drug Discovery World

MAY 6, 2024

However, France had been falling behind other nations like the US and UK, so to redress the balance, the French government launched the €7.5 The transfer of technologies from the lab to the market, is no longer purely via IP out licensing, but rather via start-up M&A deals – start-ups being the de-risking vehicle for large corporates.

Drugs 147

Drugs Science Molecular Biology Clinical Trials 147

Drug Discovery World

AUGUST 3, 2023

Medical cannabis is often a first-thought when regarding plant-based medicines, but there remains public scepticism, arguably due to the regulations relating to the substance. Even still, these approved drug products require a licensed healthcare provider’s prescription. What is the regulatory landscape of medical cannabis?

Clinical Trials 130

Clinical Trials Regulations Production FDA 130

The Pharma Data

JANUARY 4, 2021

We believe our allogenic CAR-T platform is significantly stronger with chPD1 target licensed from Longwood University. relevant government policies and regulations relating to our industry. Amorette Barber of Longwood University will be heading up our chPD1 program. “We believe Prof. About Longwood University.

Molecular Biology 40

Molecular Biology Therapies Immune Response Science 40

Codon

JULY 27, 2023

.” Wellcome Collection , London I wrapped up my series on “30 Days of Great Biology Papers.” ” This was a series of tweets in which I told brief stories behind seminal papers, mostly in molecular biology and biophysics. You can read all of them here. And it’s true, but only in an incomplete way.

Therapies 52

Therapies RNA DNA Engineering 52

Codon

JULY 27, 2023

.” Wellcome Collection , London I wrapped up my series on “30 Days of Great Biology Papers.” ” This was a series of tweets in which I told brief stories behind seminal papers, mostly in molecular biology and biophysics. You can read all of them here. And it’s true, but only in an incomplete way.

Therapies 52

Therapies RNA DNA Engineering 52

The Pharma Data

DECEMBER 2, 2020

Most vaccines take 20 to 30 years to be licensed. To have multiple vaccines licensed within a year of the pathogen being discovered is unprecedented. Earlier in the year, “There was great concern that the government would pressure the FDA to make a decision before the process worked itself out,” she said.

Vaccine 52

Vaccine FDA Molecular Biology Licensing 52